Tobramycin inhalation solution

( DrugBank: Tobramycin / KEGG DRUG: Tobramycin )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	53

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

trials per page:

Showing 1 to 10 of 53 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02657473 (ClinicalTrials.gov)	August 13, 2016	13/1/2016	Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis	Long-term Inhaled Nebulized Tobramycinin Patients With Non-cystic Fibrosis Bronchiectasis. A Randomi ...	Non-CF Bronchiectasis	Drug: tobramycin inhalation solution;Drug: Saline 0.9% inhalation solution	Medical Center Alkmaar	NULL	Completed	18 Years	N/A	All	58	Phase 2/Phase 3	Netherlands
2	EUCTR2016-000166-35-NL (EUCTR)	08/08/2016	17/05/2016	Inhaled nebulized tobramycin in non-CF bronchiectasis	Effects of long term ToBrAmycin InhalaTion SoluTion(TIS) once daiLy on Exacerbation rate in patients ...	Patients with non-cystic fibrosis bronchiectasis MedDRA version: 19.0;Level: PT;Classification code ...	Trade Name: Tobramycin Steri-Neb 300 mg/5 ml, inhalation solution	Noordwest Ziekenhuisgroep	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2;Phase 3	Netherlands
3	EUCTR2012-001565-33-IE (EUCTR)	08/01/2015	11/09/2014	An open-label clinical trial that compares how long it takes in total for a patient with cystic fibr ...	An open-label, crossover, interventional Phase IV study to compare the ease of use of tobramycin inh ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosispatients MedDRA version: 17.0;L ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	67	Phase 4	Spain;Ireland;Germany;United Kingdom;Switzerland
4	EUCTR2014-001204-21-DE (EUCTR)	17/11/2014	22/08/2014	An open-label clinical trial that evaluates the lung clearance index in cystic fibrosis patients = 6 ...	An 8 week open-label interventional multicenter study to evaluate the lung clearance index as endpoi ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosispatients MedDRA version: 18.0;L ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Pharma GmbH	NULL	Not Recruiting			Female: yes Male: yes		Phase 4	Germany
5	EUCTR2014-001401-41-NL (EUCTR)	29/07/2014	15/05/2014	Once daily deep inhalationof tobramycinwith smart nebulizer more effective to treat small airways di ...	Targeting Antibiotics to Pseudomonas Aeruginosa in Small airways (TAPAS) study in patients with cyst ...	Cystic Fibrosis and chronic infection with Pseudomonas aeruginosa;Therapeutic area: Diseases [C] - R ...	Trade Name: Bramitob 300mg/4ml Nebuliser Solution		NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	26		Netherlands
6	NCT02054156 (ClinicalTrials.gov)	June 2014	1/2/2014	OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis	OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Mul ...	Cystic Fibrosis	Drug: azithromycin;Drug: placebo;Drug: Tobramycin solution for inhalation	Bonnie Ramsey	National Heart, Lung, and Blood Institute (NHLBI)	Completed	6 Months	18 Years	All	221	Phase 3	United States
7	EUCTR2013-004295-35-AT (EUCTR)	30/04/2014	02/04/2014	Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalationin ...	Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalationin ...	Chronic lung P. Aeruginosa Infection MedDRA version: 16.1;Level: PT;Classification code 10061229;Ter ...	Trade Name: Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler P ...	Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III)	NULL	Not Recruiting			Female: yes Male: yes	15	Phase 4	Austria
8	EUCTR2009-016590-15-PL (EUCTR)	03/12/2013	11/10/2013	A clinical trial to assess the treatment with nebulised tobramycinin terms of safety and ability to ...	A Randomized, Double-Blind, Placebo-Controlled, Crossover Multi-Center Study to Assess the Efficacya ...	Lung colonisation with Pseudomonas aeruginosa in cystic fibrosis patients MedDRA version: 14.1;Level ...	Trade Name: TOBI 300 mg / 5 mL nebuliser solution INN or Proposed INN: Tobramycin	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	50		United States;Greece;Russian Federation;Switzerland;Italy;France;Egypt;Hungary;Canada;Argentina;Pola ...
9	NCT01844778 (ClinicalTrials.gov)	August 2013	29/4/2013	Ease of Use and Microbial Contamination of Tobramycin InhalationPowder (TIP) Versus Nebulised Tobram ...	An Open-label, Crossover, Interventional Phase IV Study to Compare the Ease of Use of TIP With Nebul ...	Cystic Fibrosis	Drug: Tobramycin Inhalation Powder;Drug: Tobramycin inhalation solution;Drug: Colistimethate	Novartis Pharmaceuticals	NULL	Completed	6 Years	N/A	All	60	Phase 4	Germany;Ireland;Spain;Switzerland;United Kingdom
10	EUCTR2012-001565-33-ES (EUCTR)	04/07/2013	16/05/2013	An open-label clinical trial that compares how long it takes in total for a patient with cystic fibr ...	An open-label, crossover, interventional Phase IV study to compare the ease of use of tobramycin inh ...	Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosispatients MedDRA version: 16.0;L ...	Trade Name: TOBI Podhaler Product Name: TOBI Podhaler Product Code: TBM100C INN or Proposed INN: Tobram ...	Novartis Farmaceutica, S.A.	NULL	Not Recruiting			Female: yes Male: yes	67	Phase 4	Spain;Ireland;Germany;United Kingdom;Switzerland

First Previous1 2 3 4 5 6Next Last